Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This preliminary, open-label study assesses the feasibility of 34mg at bedtime for 6 weeks in
Veterans with Posttraumatic Stress Disorder and insomnia.